The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease

Abstract

Background:

Evaluation of health-related quality of life (HRQL) is important in improving the quality of patient care.

Methods:

The HeartQoL Project, with cross-sectional and longitudinal phases, was designed to develop a core ischemic heart disease (IHD) specific HRQL questionnaire, to be called the HeartQoL, for patients with angina, myocardial infarction (MI), or ischemic heart failure. Patients completed a battery of questionnaires and Mokken scaling analysis was used to identify items in the HeartQoL questionnaire.

Results:

We enrolled 6384 patients (angina, n = 2111, 33.1%; MI, n = 2351, 36.8%; heart failure, n = 1922, 30.1%) across 22 countries and 15 languages. The HeartQoL questionnaire comprises 14-items with 10-item physical and 4-item emotional subscales which are scored from 0 (poor HRQL) to 3 (better HRQL) with a global score if needed. The mean baseline HeartQoL global score was 2.2 (±0.5) in the total group and was different (p < 0.001) by diagnosis (MI, 2.4 ± 0.5; angina, 2.2 ± 0.6; and heart failure, 2.1 ± 0.6).

Conclusion:

The HeartQoL questionnaire, with global and subscale scores, has the potential to allow clinicians and researchers to (a) assess baseline HRQL, (b) make between-diagnosis comparisons of HRQL, and (c) evaluate change in HRQL in patients with angina, MI, or heart failure with a single IHD-specific HRQL instrument.

Keywords

Ischemic heart disease angina myocardial infarction heart failure health-related quality of life

Get full access to this article

View all access options for this article.

References

Institute of Medicine. Crossing the quality chasm: A new health system for the twenty-first century, Washington DC: National Academy Press, 2001.

Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: European Medicines Agency, 2005. Available at: www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf.

US Department of Health and Human Services. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Washington DC: Food and Drug Administration, 2009. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.

Testa

Simonson

. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 835–840.

Aaronson

Ahmedzai

Bergman

. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.

Cella

Tulsky

Gray

. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570–579.

Allender

Scarborough

Peto

. European cardiovascular disease statistics 2008, Brussels: European Heart Network, 2008.

Kochanek

Murphy

. Deaths: preliminary data for 2009. Natl Vital Stat Rep 2011; 59: 1–51.

Krumholz

Peterson

Ayanian

. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005; 111: 3158–3166.

10.

Scientific Advisory Committee of Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193–205.

11.

Spertus

Winder

Dewhurst

. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994; 74: 1240–1244.

12.

Spertus

Winder

Dewhurst

. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333–341.

13.

Lim

LL-Y

Valenti

Knapp

. A self-administered quality of life questionnaire after acute myocardial infarction. J Clin Epidemiol 1993; 46: 1249–1256.

14.

Valenti

Lim

Heller

. An improved questionnaire for assessing quality of life after myocardial infarction. Qual Life Res 1996; 5: 151–161.

15.

Rector

Kubo

Cohn

. Patients' self-assessment of their congestive heart failure: Part 2. Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Fail 1987; 3: 198–209.

16.

Rector

Cohn

. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992; 124: 1017–1025.

17.

Oldridge

Saner

McGee

. The Euro Cardio-QoL Project. An international study to develop a core heart disease health-related quality of life questionnaire, the HeartQoL. Eur J Cardiovasc Prev Rehabil 2005; 12: 87–94.

18.

Oldridge N, Höfer S, McGee H, et al. The HeartQoL: II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol (in press).

19.

Ware

The SF-36 Health Survey. In: Spilker

(eds). Quality of life and pharmacoeconomics in clinical trials, Philadelphia: Lippincott-Raven, 1996, pp. 337–345.

20.

Ware

Jr . SF-36 health survey update. Spine 2000; 25: 3130–3139.

21.

Zigmond

Snaith

. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.

22.

Snaith

. The hospital anxiety and depression scale. Health Qual Life Outcomes 2003; 1: 29–32.

23.

Bullinger

Alonso

Apolone

. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 913–923.

24.

Juniper

Guyatt

Streiner

. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997; 50: 233–238.

25.

Molenaar

Nonparametric models for polytomous responses. In: Van der Linden

Hambleton

(eds). Handbook of modern item response theory, New York: Springer-Verlag, 1997, pp. 369–380.

26.

Meijer

Baneke

. Analyzing psychopathology items: a case for nonparametric item response theory modeling. Psychol Methods 2004; 9: 354–368.

27.

Embertson

Reise

. Item response theory for psychologists, Mahwah, NJ: Lawrence Erlbaum Associates, Inc., 2000.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB